Rifampicin
10-003108
Phase 3 small_molecule terminated
Quick answer
Rifampicin for Multiple System Atrophy is a Phase 3 program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Multiple System Atrophy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated